Followers | 177 |
Posts | 24415 |
Boards Moderated | 12 |
Alias Born | 04/03/2002 |
Wednesday, October 24, 2007 8:55:11 AM
MELVILLE, N.Y., Oct 24, 2007 (BUSINESS WIRE) -- FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning(TM) announced today that a third FONAR UPRIGHT(R) Multi-Position(TM) MRI has been sold in Germany. The unit is expected to be installed early next year in a diagnostic outpatient facility in the city of Munich. This is the fourth FONAR UPRIGHT(R) Multi-Position(TM) MRI sold by Tecserena GmbH, FONAR's European distributor since 2006.
FONAR has now reported 161 UPRIGHT(R) MRI scanners sold, with eleven occurring during the quarter ending September 30, 2007. In a September 28, 2007 press release, Dr. Raymond Damadian, president and founder of FONAR said, "In addition, we are receiving UPRIGHT(R) Multi-Position(TM) MRI orders in the first quarter of Fiscal 2008 at one of the highest levels we have experienced since the product was introduced." It is notable that only three (3) quarterly totals have topped this number since FONAR began selling the UPRIGHT(R) MRI in October, 2000.
The first unit in Germany was installed in Cologne in February 2006. On June 13, 2007, Dr. Raymond Damadian, helped dedicate the UPRIGHT(R) MRI facility at Hanover by speaking to the gathered medical audience at the grand opening.
Alfred Schlemmer, managing director of Tecserena, said, "Both the Hanover and Cologne UPRIGHT(R) MRI centers have been very busy and we have been able to turn their successes into a third sale in Munich. However, the most compelling aspect of this scanner is its ability to see the body in its dynamic and functional state. Our growing base of referring physicians are very delighted with the capabilities and image quality of the FONAR UPRIGHT(R) Multi-Position(TM) MRI."
Mr. Schlemmer continued, "The FONAR UPRIGHT(R) Multi-Position(TM) MRI is a most unique MRI scanner. We firmly believe that it will become a standard in MRI diagnostics in Europe, especially of the spine. No other medical diagnostic product can put together in one scanner the detailed imaging of an MRI with the capability to image in any position that the patient can get into. Our basic marketing strategy is to educate the medical community about the unique diagnostic capabilities of the FONAR unit. Once the marketplace understands them, sales follow."
Dr. Damadian said, "Nothing is more gratifying than a customer who has actually used your product and wants to buy more!"
Tecserena was established as a distributor for FONAR's MRI products in Europe by Matthias Schulz, Alfred Schlemmer and Holger Frey. For additional information about Tecserena, visit www.tecserena.com, or call +49 221 340 2890.
The Inventor of MR Scanning(TM), Full Range of Motion(TM), pMRI(TM), Multi-Position(TM), True Flow(TM) and The Proof is in the Picture(TM) are trademarks and UPRIGHT(R) and STAND-UP(R) are registered trademarks of FONAR Corporation.
Be sure to visit FONAR's Website for product and investor information: www.fonar.com
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company filings with the Securities and Exchange Commission.
SOURCE: FONAR Corporation
CONTACT: FONAR Corporation
Daniel Culver, 631-694-2929
Fax: 631-390-1709
http://www.fonar.com
invest2007@fonar.com
Copyright Business Wire 2007
Recent FONR News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:20:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:13:55 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:05:17 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 02:36:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 06:44:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 07:35:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 07:37:09 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM